NEW YORK (Reuters Health) – BRCA2, but not BRCA1, gene mutation is associated with improved survival and response to chemotherapy in women with high-grade serous ovarian cancer, an…
NEW YORK (Reuters Health) – The sensitivity of currently available PCR-based assays for diagnosing sepsis in newborns is not yet high enough to replace microbial cultures, according to…
NEW YORK (Reuters Health) – A large increase in the number of lymph nodes evaluated during surgery for colon cancer — a quality improvement metric– has not had…
NEW YORK (Reuters Health) – Measuring homocysteine improves the accuracy of estimated risk of cardiovascular events, according to an analysis of data from two different sources. “Our observations…
NEW YORK (Reuters Health) – Algorithms based on procalcitonin (PCT) measurements reduce the use of antibiotics without jeopardizing patient safety, according to a review of randomized clinical trials.…
NEW YORK (Reuters Health) – No chemotherapy sensitivity and resistance assays have sufficient supporting evidence to justify their use in oncology practice. That’s the conclusion of an American…
NEW YORK (Reuters Health) – In women undergoing breast-conserving therapy for early breast cancer, the presence of occult metastasis not seen with routine pathological examination in sentinel lymph…
NEW YORK (Reuters Health) – In infants and young children with cystic fibrosis, treating Pseudomonas aeruginosa infection based on bronchoalveolar lavage (BAL) rather than oropharyngeal cultures does not…
It’s Day One of the 71st Scientific Sessions of the American Diabetes Association, and more than 13,000 diabetes experts are gathered in San Diego. Check back daily for…
NEW YORK (Reuters Health) – After chemotherapy-induced remission of follicular lymphoma, vaccination with a patient-specific tumor-derived antigen improves disease-free survival, a multicenter team has shown. Furthermore, the vaccine…
